Inflammasome Therapeutics, Inc. funding
Inflammasome Therapeutics, Inc., a biotechnology company based in Newton, MA, filed a Form D with the SEC on May 4, 2026 and reported $13.2M raised.
Amount raised$13.2M
Offering size$13.2M
Filed with the SECMay 4, 2026
First saleFebruary 27, 2026
IndustryBiotechnology
SecuritiesEquity
LocationNewton, MA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far62
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed May 4
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care